Biotech entity
pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention China, the most common co-covered peer. Hainan Boao Lecheng appears in 1 tracked Biotech story from March 7, 2026. The tracked stories average 2 original sources each.
Last mentioned: Mar 7, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention China, the most common co-covered peer. Hainan Boao Lecheng appears in 1 tracked Biotech story from March 7, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 7 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Hainan Boao Lecheng. Shared-story counts are live from our verified record — not editorial picks.
Annual Progress Review
First assessment of the 15th Five-Year Plan's initial biotech milestones.
R&D Tax Incentive Launch
Specialized tax breaks for high-tech biotech firms are rolled out nationwide.
NMPA Reform Implementation
New guidelines for accelerated clinical trial approvals take effect.
Policy Framework Unveiled
China details the 2026 policy mix focusing on innovation and global sharing.
China has detailed a comprehensive 2026 policy framework aimed at accelerating domestic biotech innovation while expanding international market access. The initiative prioritizes 'new quality productive forces' in drug development and streamlines regulatory pathways for global pharmaceutical collaborations.
Hainan Boao Lecheng is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
